Reversible bilateral internuclear ophthalmoplegia associated with FK506

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 5, 2004, Pages 776-778

  Lai, M M ^a   Kerrison, J B ^a   Miller, N R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DIGOXIN; LEVOTHYROXINE; LISINOPRIL; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; DIPLOPIA; GRAFT REJECTION; HEART GRAFT; HUMAN; INTERNUCLEAR OPHTHALMOPLEGIA; MALE; NEUROTOXICITY; PRIORITY JOURNAL; TONIC CLONIC SEIZURE;

GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OCULAR MOTILITY DISORDERS; TACROLIMUS;

EID: 1942453283     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.027375     Document Type: Article

References (14)

1. Ho S, Clipstone N, Timmermann L, et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 1996;80:S40-5.
2. Wechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000;13:313-26.
3. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246:339-46.
4. Misawa A, Takeuchi Y, Hibi S, et al. FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25:331-4.
5. Eidelman BH, Abu-Elmagd K, Wilson J, et al. Neurologic complications of FK 506. Transplant Proc 1991;23:3175-8.
6. Woo M, Przepiorka D, Ippoliti C, et al. Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation. Bone Marrow Transplant 1997;20:1095-8.
7. Yakel JL. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol Sci 1997;18:124-34.
8. Snyder SH, Lai MM, Burnett PE. Immunophilins in the nervous system. Neuron 1998;21:283-94.
9. Lai MM, Luo HR, Burnett PE, et al. The calcineurin-binding protein cain is a negative regulator of synoptic vesicle endocytosis. J Biol Chem 2000;275:34017-20.
10. Lyson T, Ermel LD, Belshaw PJ, et al. Cyclosporine-and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling. Circ Res 1993;73:596-602.
11. Oliverio PJ, Lucas R, Mitchell SA, et al. Reversible tacrolimus-induced neurotoxicity isolated to the brain stem. Am J Neuroradiol 2000;21:1251-4.
12. Openshaw H, Slatkin NE, Smith E. Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir. Bone Marrow Transplant 1997;19:503-5.
13. McMaster P, Mirza DF, Ismail T, et al. Therapeutic drug monitoring of tocrolimus in clinical transplantation. Ther Drug Monit 1995;17:602-5.
14. Selzner N, Durand F, Bernuau J, et al. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. Transplantation 2001;72:1061-5.